Advertisement
Singapore markets closed

  • Straits Times Index

    3,280.10
    -7.65 (-0.23%)
     

  • Nikkei

    37,934.76
    +306.28 (+0.81%)
     

  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     

  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     

  • Bitcoin USD

    64,034.06
    -450.29 (-0.70%)
     

  • CMC Crypto 200

    1,332.34
    -64.20 (-4.60%)
     

  • S&P 500

    5,105.75
    +57.33 (+1.14%)
     

  • Dow

    38,292.83
    +207.03 (+0.54%)
     

  • Nasdaq

    15,925.13
    +313.37 (+2.01%)
     

  • Gold

    2,351.80
    +9.30 (+0.40%)
     

  • Crude Oil

    83.74
    +0.17 (+0.20%)
     

  • 10-Yr Bond

    4.6710
    -0.0350 (-0.74%)
     

  • FTSE Bursa Malaysia

    1,575.16
    +5.91 (+0.38%)
     

  • Jakarta Composite Index

    7,036.08
    -119.22 (-1.67%)
     

  • PSE Index

    6,628.75
    +53.87 (+0.82%)
     

iCAD to Participate at the Imagine AI + Healthcare Investor Summit

icad inc.
·1-min read

NASHUA, N.H., Dec. 06, 2021 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that Stacey Stevens, President and incoming Chief Executive Officer, will present a corporate overview at Oppenheimer’s Imagine AI + Healthcare Investor Summit being hosted by Oppenheimer in partnership with the Alliance for AI in Healthcare (AAIH).

Oppenheimer’s Imagine AI + Healthcare Investor Summit
Date: Tuesday, December 7th
Time: 11:00 a.m. to 11:20 a.m. ET
Registration Link

About iCAD, Inc.
Headquartered in Nashua, NH, iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. For more information, visit www.icadmed.com.

Contact:
Media Inquiries:
Jessica Burns, iCAD
+1-201-423-4492
jburns@icadmed.com

Investor Relations:
Brian Ritchie, LifeSci Advisors
+ 1-212-915-2578
britchie@lifesciadvisors.com